JohnHiltonMD

PubMed

• 6 citations
  Polysomnographic Markers of Obstructive Sleep Apnea Severity and Cancer-Related Mortality: A Large Retrospective Multicenter Clinical Cohort Study.
  Tetyana Kendzerska, Andrea S. Gershon, Marcus Povitz, Mark I. Boulos, Brian J. Murray, Daniel I. McIsaac, Gregory L. Bryson, Robert Talarico, John Hilton, Atul Malhotr...> ;Annals of the American Thoracic Society. 2021 Nov 17
• 6 citations
  Time to Update Evidence-Based Guideline Recommendations About Concurrent Tamoxifen and Antidepressant Use? A Systematic Review.
  Michelle Bradbury, Brian Hutton, Ana-Alicia Beltran-Bless, Mashari Alzahrani, Thomas Lariviere, Ricardo Fernandes, Mohammed F.K. Ibrahim, Katherine Cole, John Hilton, ...> ;Clinical Breast Cancer. 2021 Oct 9
• 19 citations
  First-in-Class Anti-immunoglobulin–like Transcript 4 Myeloid-Specific Antibody MK-4830 Abrogates a PD-1 Resistance Mechanism in Patients with Advanced Solid Tumors
  Lillian L. Siu, Ding Wang, John Hilton, Ravit Geva, Drew W. Rasco, Ruth Perets, Anson K. Abraham, Douglas C. Wilson, Julia F. Markensohn, Jared Lunceford, Leah Suttner...> ;Clinical Cancer Research. 2021 Oct 1
• 5 citations
  A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia
  Mark Clemons, Dean Fergusson, Anil A. Joy, Kednapa Thavorn, Judith Meza-Junco, Julie A. Price Hiller, John R. Mackey, Terry L. Ng, Xiaofu Zhu, Mohammed F.K. Ibrahim, M...> ;Breast. 2021 Apr 1
• 4 citations
  Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation
  Sharon F. McGee, Mashari Alzahrani, Carol Stober, Terry L. Ng, Katherine Cole, Gail Larocque, Arif Awan, Sandeep Sehdev, John Hilton, Lisa Vandermeer, Brian Hutton, Gr...> ;Journal of Bone Oncology. 2021 Feb 19
• 11 citations
  Optimising weight-loss interventions in cancer patients-A systematic review and network meta-analysis.
  Nathalie LeVasseur, Wei Cheng, Sasha Mazzarello, Mark Clemons, Lisa Vandermeer, Lee W. Jones, Anil A. Joy, Pauline Barbeau, Dianna Wolfe, Nadera Ahmadzai, Mona Hersi, ...> ;Plos One. 2021 Feb 4
• 36 citations
  A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer
  Mark Clemons, Michael Ong, Carol Stober, Scott Ernst, Christopher M. Booth, Christina Canil, Mihaela Mates, Andrew Robinson, Phillip S. Blanchette, Anil A. Joy, John H...> ;European Journal of Cancer. 2021 Jan 1
• 25 citations
  Obstructive Sleep Apnea and Incident Cancer: A Large Retrospective Multicenter Clinical Cohort Study.
  Tetyana Kendzerska, Marcus Povitz, Richard S. Leung, Mark I. Boulos, Daniel I. McIsaac, Brian J. Murray, Gregory L. Bryson, Robert Talarico, John Hilton, Atul Malhotra...> ;Cancer Epidemiology, Biomarkers & Prevention. 2021 Feb 1
• 9 citations
  A randomized trial of individualized versus standard of care antiemetic therapy for breast cancer patients at high risk for chemotherapy-induced nausea and vomiting.
  Mark Clemons, G. Dranitsaris, Marta Sienkiewicz, Sandeep Sehdev, Terry L. Ng, Andrew G. Robinson, M. Mates, Tina Hsu, Sharon F. McGee, Orit Freedman, V. Kumar, Dean Fe...> ;Breast. 2020 Nov 10
• 3 citations
  A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy.
  Tina Hsu, Dean Fergusson, Carol Stober, Kelly Daigle, Noorza Moledina, Lisa Vandermeer, Greg Pond, John Hilton, Brian Hutton, Mark Clemons, REaCT investigators> ;Supportive Care in Cancer. 2021 Jun 1
• 3 citations
  Potential insights from population kinetic assessment of progression-free survival curves.
  David J. Stewart, Dominick Bossé, Andrew Robinson, Michael Ong, Michael Fung-Kee-Fung, Stephanie Brule, John Hilton, Alberto Ocaña> ;Critical Reviews in Oncology/hematology. 2020 Sep 1
• 19 citations
  A multicentre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early s...
  Mark Clemons, Dean Fergusson, Demetrios Simos, M. Mates, Andrew Robinson, Nadia Califaretti, L. Zibdawi, M. Bahl, Jacques Raphael, Mohamed F.K. Ibrahim, Ricardo Fernan...> ;Annals of Oncology. 2020 Jul 1
• 120 citations
  Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive a...
  Sara M. Tolaney, Andrew M Wardley, Stefania Zambelli, John Hilton, Tiffany A. Troso-Sandoval, Francesco Ricci, Seock-Ah Im, Sung Bae Kim, Stephen R. D. Johnston, Arlen...> ;The Lancet. Oncology. 2020 Jun 1
• 15 citations
  A phase IB study of durvalumab with or without tremelimumab and platinum-doublet chemotherapy in advanced solid tumours: Canadian Cancer Trials Group Study IND226.
  Rosalyn A. Juergens, Desiree Hao, Peter M. Ellis, Dongsheng Tu, Mihaela Mates, Christian K. Kollmannsberger, Penelope A. Bradbury, Moustapha Tehfe, Paul Wheatley-Price...> ;Lung Cancer. 2020 Feb 28
• 10 citations
  A novel, more reliable approach to use of progression-free survival as a predictor of gain in overall survival: The Ottawa PFS Predictive Model.
  David J. Stewart, Dominick Bossé, Glenwood D. Goss, John Hilton, Derek J. Jonker, Michael Fung-Kee-Fung> ;Critical Reviews in Oncology/hematology. 2020 Apr 1
• 103 citations
  Phase 1 Study of Molibresib (GSK525762), a Bromodomain and Extra-Terminal Domain Protein Inhibitor, in NUT Carcinoma and Other Solid Tumors.
  Sarina Anne Piha-Paul, Christine L. Hann, Christopher A. French, Sophie Cousin, Irene Brana, P. A. Cassier, Victor Moreno, Johann S. de Bono, Sara Duckworth Harward, G...> ;JNCI Cancer Spectrum. 2020 Apr 1
• 6 citations
  Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic Information.
  Susan J. Robertson, Greg Pond, John Hilton, Stephanie Petkiewicz, Yasmin Ayroud, Zuzana Kos, Denis H. Gravel, Carol Stober, Lisa Vandermeer, Angel Arnaout, Mark Clemons> ;Clinical Breast Cancer. 2020 Feb 1
• 1455 citations
  Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048) : a ...
  Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Baste, Prakash Neupane, Åse Bratland, Tho...> ;Lancet. 2019 Nov 23
• 6 citations
  OCTANE (Ontario-wide Cancer Targeted Nucleic Acid Evaluation): a platform for intraprovincial, national, and international clinical data-sharing.
  E. R. Malone, Ramy Saleh, C. Yu, L. Ahmed, Thomas J. Pugh, Jonathon Torchia, John M. S. Bartlett, Carl Virtanen, Sebastien J. Hotte, John Hilton, Stephen Welch, Andrew...> ;Current Oncology. 2019 Oct 1
• 37 citations
  A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2‐Positive Metastatic Breast Cancer (CCTG IND.229)
  Stephen Chia, Phillipe L. Bedard, John Hilton, Eitan Amir, Karen A. Gelmon, Rachel Anne Goodwin, Diego Villa, Michael Cabanero, Dongsheng Tu, Ming Tsao, Lesley Seymour> ;The Oncologist. 2019 Aug 16
• 7 citations
  Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients.
  Angel Arnaout, Susan J. Robertson, Gregory R. Pond, Reinhold Vieth, Ahwon Jeong, John Hilton, Timothy Ramsey, Mark Clemons> ;Breast Cancer Research and Treatment. 2019 Aug 9
• 42 citations
  A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients.
  Angel Arnaout, Susan J. Robertson, Gregory R. Pond, Hoyun Lee, Ahwon Jeong, Luisa Ianni, Lynne Kroeger, John Hilton, Stuart G Coupland, Chloe Gottlieb, Bernard Hurley,...> ;Breast Cancer Research and Treatment. 2019 Aug 7
• Why “Reply All” Can Push All the Wrong Buttons
  Sharon McGee, Mark Clemons, Anil Abraham Joy, John Hilton, Ahwon Jeong, Andrew Robinson> ;The Oncologist. 2019 Aug 1
• 16 citations
  Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT).
  Bassam Basulaiman, Arif Awan, Dean Fergusson, Lisa Vandermeer, Angel Arnaout, John Hilton, Brian Hutton, Anil Abraham Joy, Andrew Robinson, Nadia Califaretti, Carol St...> ;Breast Cancer Research and Treatment. 2019 May 24
• 18 citations
  De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis.
  Arif Awan, Brian Hutton, John Hilton, Sasha Mazzarello, Catherine Van Poznak, Lisa Vandermeer, Brianne Bota, Carol Stober, Marta Sienkiewicz, Dean Fergusson, Risa Shor...> ;Breast Cancer Research and Treatment. 2019 May 11
• Join now to see all